Corcept Therapeutics (CORT) FCF Margin (QoQ) (2012 - 2026)

Corcept Therapeutics (CORT) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,929.00
Dec 31, 2025 -724.00
Sep 30, 2025 348.00
Jun 30, 2025 1,979.00
Mar 31, 2025 -2,998.00
Dec 31, 2024 -630.00
Sep 30, 2024 1,436.00
Jun 30, 2024 871.00
Mar 31, 2024 1,210.00
Dec 31, 2023 -3,869.00
Sep 30, 2023 694.00
Jun 30, 2023 1,127.00
Mar 31, 2023 -780.00
Dec 31, 2022 -36.00
Sep 30, 2022 1,530.00
Jun 30, 2022 -2,018.00
Mar 31, 2022 -1,234.00
Dec 31, 2021 -55.00
Sep 30, 2021 222.00
Jun 30, 2021 1,644.00